Mitchell Efros

846 citations

25 papers · 594 indexed · h-index 14

Impact in

Urology top 5%
- Urinary Bladder and Prostate Research
Biochemistry top 10%
- Phytochemicals and Antioxidant Activities

Papers in ⓘ

Urology 8
- Urinary Bladder and Prostate Research 8
Rheumatology 7
- Pelvic floor disorders treatments 6

Co-authors: Muhammad Choudhury (4 shared papers)James L. Bailen (3 shared papers)Mohamed Bidair (3 shared papers)Marc Gittelman (2 shared papers)John F. Ward (2 shared papers)Ralph J. Henderson (1 shared paper)Tauseef Ahmed (2 shared papers)Thomas J. Haley (3 shared papers)
Journals: The Journal of Urology (7 papers)Urology (5 papers)Neurourology and Urodynamics (2 papers)Journal of Pharmaceutical Sciences (2 papers)Endocrine Practice (2 papers)
Partner nations: United States Canada Denmark

In The Last Decade

Mitchell Efros

24 papers receiving 569 citations

Peers

Countries citing papers authored by Mitchell Efros

Since Specialization

Citations

This map shows the geographic impact of Mitchell Efros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Efros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Efros more than expected).

Fields of papers citing papers by Mitchell Efros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Efros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Efros. The network helps show where Mitchell Efros may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell Efros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell Efros Line = papers co-authored together Mitchell Efros links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer Prostate Cancer and Prostatic Diseases ·Channing J. Paller, Xiquan Ye, Paulina Woźniak, BW Gillespie, Paul Sieber, R. Greengold, Benjamin R. Stockton, Bernard Hertzman, Mitchell Efros, Robyn Roper, Harley Liker, Michael A. Carducci	2012	124
2	PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study The Journal of Urology ·Marc Gittelman, Bernard Hertzman, James L. Bailen, Thomas Williams, Isaac Koziol, Ralph J. Henderson, Mitchell Efros, Mohamed Bidair, John F. Ward	2013	105
3	A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients Cancer Prevention Research ·Edward M. Messing, Jason Gee, Daniel R. Saltzstein, KyungMann Kim, Anthony diSant'Agnese, Jill Kolesar, Linda S. Harris, Adrienne Faerber, Thomas C. Havighurst, Jay M. Young, Mitchell Efros, Robert H. Getzenberg, Marcia A. Wheeler, Joseph A. Tangrea, Howard L. Parnes, Margaret G. House, J. Erik Busby, Raymond J. Hohl, Howard H. Bailey	2012	69
4	A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of OnabotulinumtoxinA 200 U to Treat Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia The Journal of Urology ·Kevin T. McVary, Claus G. Roehrborn, Emmanuel Chartier‐Kastler, Mitchell Efros, Denise Bugarin, Ru Chen, Anand Patel, Cornelia Haag‐Molkenteller	2014	31
5	Urologic complications of high-dose chemotherapy and bone marrow transplantation Urology ·Mitchell Efros, Tauseef Ahmed, Nancy Coombe, Muhammad Choudhury	1994	30
6	Evaluating the safety and potential activity of URO‐902 (hMaxi‐K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non‐neurogenic) overactive bladder syndrome and detrusor overactivity from two double‐blind, imbalanced, placebo‐controlled randomized phase 1 trials Neurourology and Urodynamics ·Eric Rovner, Toby C. Chai, Sharon Jacobs, George J. Christ, Karl‐Erik Andersson, Mitchell Efros, Victor W. Νitti, Kelvin P. Davies, Andrew McCullough, Arnold Melman	2020	27
7	Pharmacology and toxicology of praseodymium and neodymium chlorides Toxicology and Applied Pharmacology ·Thomas J. Haley, N. Komesu, Mitchell Efros, L. Koste, H.C. Upham	1964	27
8	External electrical stimulation compared with intravaginal electrical stimulation for the treatment of stress urinary incontinence in women: A randomized controlled noninferiority trial Neurourology and Urodynamics ·Roger R. Dmochowski, Catherine Lynch, Mitchell Efros, Linda Cardozo	2019	24
9	Pharmacology and Toxicology of Lutetium Chloride Journal of Pharmaceutical Sciences ·Thomas J. Haley, N. Komesu, Mitchell Efros, L. Koste, H.C. Upham	1964	19
10	Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial Urology ·Germar‐Michael Pinggera, Ferdinand Frauscher, Darius A. Paduch, Alex Bolyakov, Mitchell Efros, Jed Kaminetsky, L. Da Pozzo, Anne Esler, David A. Cox	2014	18
11	The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia The Journal of Urology ·Steven A. Kaplan, Jared Moss, Sheldon Freedman, Karl Coutinho, Ning Wu, Mitchell Efros, Dean Elterman, Richard D’Anna, Osvaldo Padron, Kaiser J. Robertson, Samuel Lawindy, Sandeep Mistry, Neal D. Shore, Jeffrey Spier, Jed Kaminetsky, Brian C. Mazzarella, David Cahn, Mark Jalkut, Alexis E. Te	2023	16
12	Interferons and interleukins in metastatic renal cell carcinoma Urology ·Muhammad Choudhury, Mitchell Efros, Abraham Mittelmang	1993	13
13	Unusual primary prostatic malignancies Urology ·Mitchell Efros, Joel Fischer, Camille Mallouh, Muhammad Choudhury, Sverrir Georgsson	1992	13
14	Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement World Journal of Urology ·Neal D. Shore, Ronald Tutrone, Mitchell Efros, Mohamed Bidair, Barton Wachs, Susan Kalota, Sheldon Freedman, James L. Bailen, Richard Levin, Stephen K. Richardson, Jed Kaminetsky, Jeffrey A. Snyder, Barry Shepard, Kenneth Goldberg, Alan R. Hay, Steven Gange, Ivan Grunberger	2018	13
15	Novel Concentrated Cranberry Liquid Blend, UTI-STAT With Proantinox, Might Help Prevent Recurrent Urinary Tract Infections in Women Urology ·Mitchell Efros, Warren D. Bromberg, Leanne Cossu, Ellen Nakeleski, Aaron E. Katz	2010	13
16	Efficacy and Safety of a New Topical Testosterone Replacement Gel Therapy for the Treatment of Male Hypogonadism Endocrine Practice ·Glenn R. Cunningham, Laurence Belkoff, Gerald Brock, Mitchell Efros, Marc Gittelman, Dario Carrara, Anders Neijber, Masakazu Ando, Jules T. Mitchel	2017	13
17	A green and black tea extract benefits urological health in men with lower urinary tract symptoms Therapeutic Advances in Urology ·Aaron E. Katz, Mitchell Efros, Jed Kaminetsky, Kelli Herrlinger, Diana Chirouzes, M. A. Ceddia	2014	9
18	Cyclophosphamide-Induced Hemorrhagic Pyelitis and Ureteritis Associated with Cystitis in Marrow Transplantation The Journal of Urology ·Mitchell Efros, Tauseef Ahmed, Muhammad Choudhury	1990	9
19	The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open-label studies Andrologia ·Mitchell Efros, Dario Carrara, Anders Neijber	2015	9
20	Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification The Journal of Urology ·Yair Lotan, Jay D. Raman, Badrinath R. Konety, Siamak Daneshmand, Florian R. Schroeck, Shahrokh F. Shariat, Peter C. Black, Michel de Lange, Scott Asroff, Evan R. Goldfischer, Mitchell Efros, Kian Tai Chong, Eugene Huang, Hong Liang Chua, Qing Wu, Siying Yeow, Weida Lau, Jin Hua Yong, M Eng	2022	6

About Mitchell Efros

Mitchell Efros is a scholar working on Urology, Rheumatology, Endocrinology, Diabetes and Metabolism, Toxicology and Pharmacology, having authored 25 papers that have together received 594 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (8 papers), Pelvic floor disorders treatments (6 papers), Hormonal and reproductive studies (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Pharmacology and Obesity Treatment (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Urinary Tract Infections Management (2 papers). The work is most often cited by research in Urology (131 citations), Biochemistry (48 citations), Rheumatology (113 citations), Pulmonary and Respiratory Medicine (179 citations) and Nutrition and Dietetics (79 citations). Mitchell Efros has collaborated with scholars based in United States, Canada and Denmark. Frequent co-authors include Muhammad Choudhury, James L. Bailen, Mohamed Bidair, Marc Gittelman, John F. Ward, Ralph J. Henderson, Tauseef Ahmed, Thomas J. Haley, Michael A. Carducci and Channing J. Paller. Their work appears in journals such as The Journal of Urology, Urology, Neurourology and Urodynamics, Journal of Pharmaceutical Sciences and Endocrine Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact